-
Apologies I don't have the time to trawl through and give you a full answer but I'm not a lone wolf here. Whole countries have stopped using AZ and J&J for example - Italy (AZ to over 60's only), Denmark (AZ and J&J unless you ask for it).
https://www.virology.ws/2017/12/07/a-problem-with-dengue-virus-vaccine/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290032/
Some easy to understand language and good discussion in the comments around the timescales for ADE to start being observed -
"I spent quite few years working on dengue ADE. I tried to build a dengue mouse model using wild-type mouse by mixing anti-dengue antibody with virus particles before infecting mice. In my hand, I could only observe ADE with lower concentration of antibody. Too much antibody then I can not see ADE.
For people with less experience in ADE, it’s easy to think when you don’t see ADE NOW, you won’t see ADE in the FUTURE. Philippine actually realized there is ADE from dengue vaccine after 3 years.
For COVID vaccine, I’d suggest setting up an animal study with serial diluted vaccines and longer observation time to observe whether weaker immune response or waned antibody would elicit ADE."We haven't even discussed the spike protein yet -
https://www.regulations.gov/document/FDA-2020-N-1898-0246
Anyway I'm obviously a nasty c*nt who doesnt care about anyone but himself so i'm going to leave it there. Keep healthy and make sure you take your Vitamins.
You are reading a single comment by @8b and its replies.
Click here to read the full conversation.
8b
And on basis are you identifying the benefits and risks? Research, science and epidemiology or guesswork, 'impressions', and cheap digs at pharmaceutical companies?
Name one.